Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| 9924 | ETCTN | A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients with Relapsed or Refractory Non-Hodgkins Lymphoma (NHL) | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9925 | ETCTN | Phase II Trial of Nivolumab for HTLV-Associated Adult T Cell Leukemia/Lymphoma | Adult CIRB - Early Phase Emphasis | Completed | |
| 9930 | ETCTN | A Phase I Trial of MEDI-570 in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL) | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9938 | ETCTN | Phase I clinical trial of VX-970 in combination with the topoisomerase I inhibitor irinotecan in patients with advanced solid tumors | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9944 | ETCTN | Phase 2 Study of M6620 (VX-970) in Combination with gemcitabine versus gemcitabine alone in Subjects with Platinum-Resistant Recurrent Ovarian or Primary Peritoneal Fallopian Tube Cancer | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9947 | ETCTN | A Randomized Phase 2 Trial of Cisplatin/Gemcitabine with or without M6620 (VX-970) in Metastatic Urothelial Carcinoma | Adult CIRB - Early Phase Emphasis | Completed | |
| 9948 | ETCTN | Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine with or without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9950 | ETCTN | A Phase I Study of M6620 (VX-970) in Combination with Cisplatin and XRT in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121) | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9952 | ETCTN | Phase 1 Trial to Determine the Recommended Phase 2 Dose (RP2D) of M6620 (VX‐970) When Combined with Whole Brain Radiotherapy (WBRT) in Patients with Brain Metastases from Lung Cancer | Adult CIRB - Early Phase Emphasis | Completed | |
| 9974 | ETCTN | A phase II study of olaparib plus cediranib in combination with standard therapy for small cell lung cancer | Adult CIRB - Early Phase Emphasis | Completed |